Unknown

Dataset Information

0

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib


ABSTRACT: Cytokeratin 19-positive (CK19+) hepatocellular carcinoma (HCC) is an aggressive subtype characterized by early recurrence and chemotherapy tolerance. However, there is no specific therapeutic option for CK19+ HCC. The correlation between tumor recurrence and expression status of CK19 were studied in 206 patients undergoing liver transplantation for HCC. CK19−/+ HCC cells were isolated to screen effective antitumor drugs. The therapeutic effects of regorafenib were evaluated in patient-derived xenograft (PDX) models from 10 HCC patients. The mechanism of regorafenib on CK19+ HCC was investigated. CK19 positiveness indicated aggressiveness of tumor and higher recurrence risk of HCC after liver transplantation. The isolated CK19+ HCC cells had more aggressive behaviors than CK19− cells. Regorafenib preferentially increased the growth inhibition and apoptosis of CK19+ cells in vitro, whereas sorafenib, apatinib, and 5-fluorouracil did not. In PDX models from CK19−/+ HCC patients, the tumor control rate of regorafenib achieved 80% for CK19+ HCCs, whereas 0% for CK19− HCCs. RNA-sequencing revealed that CK19+ cells had elevated expression of mitochondrial ribosomal proteins, which are essential for mitochondrial function. Further experiments confirmed that regorafenib attenuated the mitochondrial respiratory capacity in CK19+ cells. However, the mitochondrial respiration in CK19− cells were faint and hardly repressed by regorafenib. The mitochondrial respiration was regulated by the phosphorylation of signal transducer and activator of transcription 3 (STAT3), which was inhibited by regorafenib in CK19+ cells. Hence, CK19 could be a potential marker of the therapeutic benefit of regorafenib, which facilitates the individualized therapy for HCC. STAT3/mitochondria axis determines the distinct response of CK19+ cells to regorafenib treatment.

SUBMITTER: Zhuo J 

PROVIDER: S-EPMC8595883 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8406635 | biostudies-literature
| S-EPMC7601489 | biostudies-literature
| S-EPMC3836575 | biostudies-literature
| S-EPMC8165525 | biostudies-literature
| S-EPMC6038776 | biostudies-literature
| S-EPMC7327090 | biostudies-literature
| S-EPMC7467441 | biostudies-literature
2021-01-27 | GSE148947 | GEO
| S-EPMC10957471 | biostudies-literature
| S-EPMC5739799 | biostudies-literature